$SHFS Cashflow Statement | Understand Stock

$SHFS

$0.09 -$0.04 (29.0%) Close

$SHFS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 10 months to Dec 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Realized gain from securities held in Trust Account
Depreciation and amortization expense
Amortization of contract asset
Stock compensation expense
Gain on extinguishment of forward purchase derivative
Amortization of prepaid consulting from the issuance of Series B Convertible Preferred Stock and Series B Warrants
Net deferred indemnified loan origination fees
Interest expense
Provision for credit loss
Discount on common stock sold pursuant to the ELOC
Other non-cash issuance costs related to the ELOC
Shares issued in settlement of a legal dispute
Non-cash interest on issuance of convertible notes
Lease expense
Credit loss (benefit) expense
Impairment of goodwill
Impairment of long-lived intangible assets
Deferred tax credit
Change in fair value of warrant and forward purchase option derivative liabilities
Deferred tax expense, net

Marketing expense settled via common stock
Marketing expense settled via Common Stock
Offering costs allocated to warrants
Change in the fair value of deferred consideration
Changes in operating assets and liabilities:
Prepaid insurance
Accounts receivable – trade
Accounts receivable – related party
Contract assets
Prepaid expenses
Forward purchase receivables
Other current liabilities
Accrued interest receivable
Deferred underwriting payable
Other current assets
Accounts payable
Accounts payable – related party
Accrued expenses
Franchise tax payable
Contract liabilities
Security deposit
Deferred revenue

Net cash (used in) provided by operating activities
Purchase of property and equipment
Change in loan receivable, net
Payment to Abaca Shareholder
Loan receivable repayment

CASH FLOWS FROM INVESTING ACTIVITIES:
Investment of cash in Trust Account
Proceeds from sale of preferred securities
Proceeds from loan repayment and sale
Net cash provided by investing activities

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of Class B common stock to sponsor
Proceeds from sale of Units, net of underwriting discount paid
Proceeds from sale of Private units
Proceeds from related party promissory note
Payment of related party promissory note
Payment of offering costs
Proceeds from reverse capitalization, net of transaction costs
Repayment of loans
Tax withholding payments on vesting of restricted stock units
Proceeds from convertible debt
Redemption of Series B Convertible Preferred Stock
Gross proceeds from issuance of Series B Convertible Preferred Stock and Series B Warrants
Offering cost
Proceeds from the sale of Class A Common Stock
Repayment of financed insurance contract
Repayment of senior secured promissory note
Net cash provided by (used in) financing activities

Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents – beginning of period
Cash and cash equivalents – end of period
Supplemental disclosure of cash flow information
Interest paid
Non cash transactions:
Deferred underwriting fee payable
Initial classification of warrant liabilities
Offering costs charged to additional paid-in capital included in accrued expense
Marketing expense settled via common stock
Reclassification of forward purchase receivable
Marketing expense settled by the issuance of Common Stock
Investment in preferred securities
Prepaid consulting expense from the issuance of the Series B Convertible Preferred Stock and Series B Warrants
Extinguishment of debt for issuance of Series B Convertible Preferred Stock and Series B Warrants
Exchange of forward purchase derivative liability for the issuance of Series B Convertible Preferred Stock and Series B Warrants
Exchange of convertible notes for Series B Convertible Preferred Stock and Series B warrants
Financed insurance contract (classified in accrued expense)
Issuance of stock to Abaca shareholders
Operating lease right of use assets recognized
Operating lease liabilities recognized
Shares issued for the settlement of PCCU debt obligation
Cumulative effect from adoption of CECL
Reversal of deferred underwriting cost
Interest recognized on PCCU settlement
Accrued redemption payable to Series B holders
Recognition of contract asset with corresponding stand-ready guarantee liability
Recognition of contract asset with corresponding financial indemnification liability

Comments